News|Articles|February 10, 2023
SCOPE 2023: Reducing Readmissions in High-Risk Patients
Author(s)Andy Studna, Senior Editor
Sunny Kumar, MD, partner at GSR Ventures speaks about reducing hospital readmissions for high-risk patients at the SCOPE 2023 conference in Orlando, FL.
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures talks about his recently-founded company and its mission to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Datavant Partner to Advance Real-World Data Interoperability Across Clinical Development
2
Applied Clinical Trials: February 2026 Interactive Digital Edition
3
Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development
4
ACT Brief: AI Scales Trial Design, ESG Becomes a Readiness Test, and Sites Push Back on Payment Practices
5